Artificial intelligence and robotics are increasingly integral in biotech, powering faster drug discovery and more efficient clinical trials. Lila Sciences secured $235 million Series A funding to scale its AI-driven scientific research platform that integrates generative AI with lab automation. Worldwide Clinical Trials aims to expand via AI investments to enhance clinical trial operations and patient data analysis. These technological advancements promise accelerated development of novel therapies and streamlined healthcare innovation workflows.